Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Thought LeadersDr. Amy Sheng, Dr. Lurong PanTechnical Account Manager, CEOSino Biological Inc., Ainnocence In this interview, NewsMedical talks to Dr. Amy Sheng, a technical account manager at Sino ...

The global molecular cloning market size is calculated at USD 5.53 billion in 2025 and is expected to reach around USD 8.89 billion by 2034, growing at a CAGR of 5.4% for the forecasted period.Ottawa, ...

Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

"If you can unlock triple digit titers this is the real game that's needed to achieve competitive pricing and profitability" ...

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from ...

(RTTNews) - Sanofi (SNYNF, SNY) announced the European Commission has granted a marketing authorization for Supemtek, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of ...

THE STRUCTURE AND FUNCTION OF RECOMBINANT HUMANIZED TYPE III COLLAGEN AS WELL AS ITS RELATED PRODUCT approved by CHINA NMPa for COSMETICS USE (ADAPTED FROM THE AUTHORS’ PUBLICATION IN Biochemical and ...

In a decision that is not very surprising but nonetheless worth taking note of, the Federal Circuit found that a reasonable jury could have found claims reciting methods using a recombinant ...